Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.
暂无分享,去创建一个
Seiji Naito | Y. Sasaguri | H. Izumi | K. Kohno | M. Shiota | E. Kashiwagi | S. Naito | A. Tanimoto | D. Masubuchi | Kimitoshi Kohno | Hiroto Izumi | N. Miyamoto | S. Nishizawa | Shigeru Nishizawa | Mayu Takahashi | Masaki Shiota | Eiji Kashiwagi | Akihide Tanimoto | Naoya Miyamoto | Akihiko Kidani | Gen Hirano | Daisuke Masubuchi | Yasushi Fukunaka | Yoshihiro Yasuniwa | Yasuyuki Sasaguri | Yoshihiro Yasuniwa | G. Hirano | A. Kidani | Mayu Takahashi | Yasushi Fukunaka | Gen Hirano | Naoya Miyamoto | Daisuke Masubuchi | Akihiko Kidani
[1] H. Allgayer,et al. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors , 2007, Oncogene.
[2] N. Sonenberg,et al. The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation , 2003, Molecular and Cellular Biology.
[3] H. Izumi,et al. Twist and p53 reciprocally regulate target genes via direct interaction , 2008, Oncogene.
[4] Michele Pagano,et al. S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth , 2006, Science.
[5] Birgit Samans,et al. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1 , 2004 .
[6] R. Weinberg,et al. Exploring a new twist on tumor metastasis. , 2006, Cancer research.
[7] S. Arii,et al. The Up-Regulation of Y-Box Binding Proteins (DNA Binding Protein A and Y-Box Binding Protein-1) as Prognostic Markers of Hepatocellular Carcinoma , 2005, Clinical Cancer Research.
[8] A. Puisieux,et al. A twist for survival and cancer progression , 2005, British Journal of Cancer.
[9] N. Colburn,et al. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. , 2005, Cancer research.
[10] Y. Sasaguri,et al. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines , 2007, Oncogene.
[11] A. Hasilik,et al. Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II , 2004, Molecular and Cellular Endocrinology.
[12] B. Samans,et al. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21 , 2004 .
[13] M. Tanimoto,et al. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. , 1996, Cancer research.
[14] Tobias Schmid,et al. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. , 2008, Cancer research.
[15] K. Yasumoto,et al. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines. , 2003, Cancer research.
[16] H. Izumi,et al. Increased Nuclear Localization of Transcription Factor Y-Box Binding Protein 1 Accompanied by Up-Regulation of P-glycoprotein in Breast Cancer Pretreated with Paclitaxel , 2005, Clinical Cancer Research.
[17] L. Kedes,et al. Twist is a potential oncogene that inhibits apoptosis. , 1999, Genes & development.
[18] N. Colburn,et al. Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion , 2006, Molecular and Cellular Biology.
[19] G. Z. Cheng,et al. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. , 2007, Cancer research.
[20] H. Samuels,et al. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis , 2004, Oncogene.
[21] G. Z. Cheng,et al. Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. , 2008, Cancer research.
[22] N. Colburn,et al. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation , 2001, Oncogene.
[23] H. Izumi,et al. ZNF143 interacts with p73 and is involved in cisplatin resistance through the transcriptional regulation of DNA repair genes , 2007, Oncogene.
[24] H. Izumi,et al. The pleiotropic functions of the Y-box-binding protein, YB-1. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[25] K. Klempnauer,et al. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun , 2004, Oncogene.
[26] Zijie Sun,et al. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both β-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells , 2008, Oncogene.
[27] H. Izumi,et al. Twist promotes tumor cell growth through YB-1 expression. , 2008, Cancer research.
[28] Xiaomeng Zhang,et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. , 2005, Cancer research.
[29] J. Massagué,et al. Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.
[30] H. Cheung,et al. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells , 2004, Oncogene.
[31] H. Uramoto,et al. Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity. , 2001, Nucleic acids research.
[32] Kou-Juey Wu,et al. Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.
[33] H. Zhang,et al. Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma , 2006, Oncogene.
[34] H. Izumi,et al. Transcription factors and drug resistance. , 2005, European journal of cancer.
[35] K. Klempnauer,et al. siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression , 2008, Oncogene.
[36] K. Yasumoto,et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. , 2004, Molecular cancer therapeutics.